EAST HANOVER, N.J., Dec. 8, 2020 /PRNewswire/ — Detailed results from the Phase III ASCEMBL study demonstrate that, at 24 weeks, asciminib (ABL001)…
Home »
Superior outcomes for acute myeloid leukemia patients in clinical trial
Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes…